產品詳情
簡單介紹：
Anti-KCNMB3抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-KCNMB3抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-KCNMB3
Cat. Number:
Anti-KCNMB3抗體KL-16908R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of Anti-KCNMB3抗體smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta subunit. The protein encoded by this gene is an auxiliary beta subunit which may partially inactivate or slightly decrease the activation time of MaxiK alpha subunit currents. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 22. [provided by RefSeq, Jul 2009]
Also known as:
BK channel subunit beta 3; BKbeta 3; BKbeta3; Calcium activated potassium channel beta 3 subunit; Calcium activated potassium Anti-KCNMB3抗體channel subfamily M subunit beta 3; Calcium activated potassium channel subunit beta 3; Charybdotoxin receptor subunit beta 3; EG435726; Gm5707; Hbeta 3; KCMB3_HUMAN; Hbeta3; K(VCA)beta 3; KCNMB 2; KCNMB 3; KCNMB2; KCNMBL; Large conductance voltage and Ca2+ activated potassium channel Maxi K beta 3 subunit; Maxi K channel subunit beta 3; Potassium channel, calcium-activated large conductance, subfamily M, beta member 3; Potassium la
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Anti-KCNMB3抗體Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human KCNMB3.
●
Predicted Molecular Weight: 31kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-KCNMB3抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-KCNMB3抗體
Optimal working dilutions must be determined by the end user.
